'To prove this is the industry's best hope': Big tobacco's support of research on the genetics of nicotine addiction

Kenneth Gundle, Molly J. Dingel, Barbara A. Koenig

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background New molecular techniques focus a genetic lens upon nicotine addiction. Given the medical and economic costs associated with smoking, innovative approaches to smoking cessation and prevention must be pursued; but can sound research be manipulated by the tobacco industry? Methodology The chronological narrative of this paper was created using iterative reviews of primary sources (the Legacy Tobacco Documents), supplemented with secondary literature to provide a broader context. The empirical data inform an ethics and policy analysis of tobacco industry-funded research. Findings The search for a genetic basis for smoking is consistent with industry's decades-long plan to deflect responsibility away from the tobacco companies and onto individuals' genetic constitutions. Internal documents reveal long-standing support for genetic research as a strategy to relieve the tobacco industry of its legal responsibility for tobacco-related disease. Conclusions Industry may turn the findings of genetics to its own ends, changing strategy from creating a 'safe' cigarette to defining a 'safe' smoker.

Original languageEnglish (US)
Pages (from-to)974-983
Number of pages10
JournalAddiction
Volume105
Issue number6
DOIs
StatePublished - Jun 1 2010
Externally publishedYes

Fingerprint

Hope
Tobacco Industry
Genetic Research
Nicotine
Tobacco
Industry
Smoking
Medical Economics
Policy Making
Constitution and Bylaws
Smoking Cessation
Research
Ethics
Tobacco Products
Lenses
Costs and Cost Analysis

Keywords

  • Genetics
  • Legacy tobacco documents
  • Tobacco industry

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health
  • Medicine(all)

Cite this

'To prove this is the industry's best hope' : Big tobacco's support of research on the genetics of nicotine addiction. / Gundle, Kenneth; Dingel, Molly J.; Koenig, Barbara A.

In: Addiction, Vol. 105, No. 6, 01.06.2010, p. 974-983.

Research output: Contribution to journalArticle

@article{c99c9912a31f4330a76ba578394d7bfd,
title = "'To prove this is the industry's best hope': Big tobacco's support of research on the genetics of nicotine addiction",
abstract = "Background New molecular techniques focus a genetic lens upon nicotine addiction. Given the medical and economic costs associated with smoking, innovative approaches to smoking cessation and prevention must be pursued; but can sound research be manipulated by the tobacco industry? Methodology The chronological narrative of this paper was created using iterative reviews of primary sources (the Legacy Tobacco Documents), supplemented with secondary literature to provide a broader context. The empirical data inform an ethics and policy analysis of tobacco industry-funded research. Findings The search for a genetic basis for smoking is consistent with industry's decades-long plan to deflect responsibility away from the tobacco companies and onto individuals' genetic constitutions. Internal documents reveal long-standing support for genetic research as a strategy to relieve the tobacco industry of its legal responsibility for tobacco-related disease. Conclusions Industry may turn the findings of genetics to its own ends, changing strategy from creating a 'safe' cigarette to defining a 'safe' smoker.",
keywords = "Genetics, Legacy tobacco documents, Tobacco industry",
author = "Kenneth Gundle and Dingel, {Molly J.} and Koenig, {Barbara A.}",
year = "2010",
month = "6",
day = "1",
doi = "10.1111/j.1360-0443.2010.02940.x",
language = "English (US)",
volume = "105",
pages = "974--983",
journal = "Addiction",
issn = "0965-2140",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - 'To prove this is the industry's best hope'

T2 - Big tobacco's support of research on the genetics of nicotine addiction

AU - Gundle, Kenneth

AU - Dingel, Molly J.

AU - Koenig, Barbara A.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Background New molecular techniques focus a genetic lens upon nicotine addiction. Given the medical and economic costs associated with smoking, innovative approaches to smoking cessation and prevention must be pursued; but can sound research be manipulated by the tobacco industry? Methodology The chronological narrative of this paper was created using iterative reviews of primary sources (the Legacy Tobacco Documents), supplemented with secondary literature to provide a broader context. The empirical data inform an ethics and policy analysis of tobacco industry-funded research. Findings The search for a genetic basis for smoking is consistent with industry's decades-long plan to deflect responsibility away from the tobacco companies and onto individuals' genetic constitutions. Internal documents reveal long-standing support for genetic research as a strategy to relieve the tobacco industry of its legal responsibility for tobacco-related disease. Conclusions Industry may turn the findings of genetics to its own ends, changing strategy from creating a 'safe' cigarette to defining a 'safe' smoker.

AB - Background New molecular techniques focus a genetic lens upon nicotine addiction. Given the medical and economic costs associated with smoking, innovative approaches to smoking cessation and prevention must be pursued; but can sound research be manipulated by the tobacco industry? Methodology The chronological narrative of this paper was created using iterative reviews of primary sources (the Legacy Tobacco Documents), supplemented with secondary literature to provide a broader context. The empirical data inform an ethics and policy analysis of tobacco industry-funded research. Findings The search for a genetic basis for smoking is consistent with industry's decades-long plan to deflect responsibility away from the tobacco companies and onto individuals' genetic constitutions. Internal documents reveal long-standing support for genetic research as a strategy to relieve the tobacco industry of its legal responsibility for tobacco-related disease. Conclusions Industry may turn the findings of genetics to its own ends, changing strategy from creating a 'safe' cigarette to defining a 'safe' smoker.

KW - Genetics

KW - Legacy tobacco documents

KW - Tobacco industry

UR - http://www.scopus.com/inward/record.url?scp=77951982812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951982812&partnerID=8YFLogxK

U2 - 10.1111/j.1360-0443.2010.02940.x

DO - 10.1111/j.1360-0443.2010.02940.x

M3 - Article

C2 - 20659058

AN - SCOPUS:77951982812

VL - 105

SP - 974

EP - 983

JO - Addiction

JF - Addiction

SN - 0965-2140

IS - 6

ER -